Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph D Mocanu

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer Cell International|June 19, 2012
Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agentNehad M Alajez, Joseph D Mocanu, Tiffany Krushel, et al.
Plos One|June 30, 2012
Cost-effectiveness of adding cetuximab to platinum-based chemotherapy for first-line treatment of recurrent or metastatic head and neck cancerMalek B Hannouf, Chander Sehgal, Jeffrey Q Cao, et al.
Biotechniques|July 2, 2008
Increased efficiency for performing colony formation assays in 96-well plates: novel applications to combination therapies and high-throughput screeningDavid Katz, Emma Ito, Ken S Lau, et al.
International Journal of Nanomedicine|November 21, 2007
Evaluation of copolymers of N-isopropylacrylamide and 2-dimethyl(aminoethyl)methacrylate in nonviral and adenoviral vectors for gene delivery to nasopharyngeal carcinomaJim Moselhy, Swapna Sarkar, Maria C Chia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Imaging and modulating antisense microdistribution in solid human xenograft tumor modelsJoseph D Mocanu, Kenneth W Yip, Julia Skliarenko, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysisAlexander V Louie, George Rodrigues, Malek Hannouf, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|June 6, 2008
The influence of hypoxia on bioluminescence in luciferase-transfected gliosarcoma tumor cells in vitroEduardo H Moriyama, Mark J Niedre, Mark T Jarvi, et al.
Molecular Cancer Therapeutics|September 21, 2006
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agentKenneth W Yip, Emma Ito, Xinliang Mao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancerKenneth W Yip, Wei Shi, Melania Pintilie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screenKenneth W Yip, Xinliang Mao, P Y Billie Au, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Cell International|June 19, 2012
Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agentNehad M Alajez, Joseph D Mocanu, Tiffany Krushel, et al.
Plos One|June 30, 2012
Cost-effectiveness of adding cetuximab to platinum-based chemotherapy for first-line treatment of recurrent or metastatic head and neck cancerMalek B Hannouf, Chander Sehgal, Jeffrey Q Cao, et al.
Biotechniques|July 2, 2008
Increased efficiency for performing colony formation assays in 96-well plates: novel applications to combination therapies and high-throughput screeningDavid Katz, Emma Ito, Ken S Lau, et al.
International Journal of Nanomedicine|November 21, 2007
Evaluation of copolymers of N-isopropylacrylamide and 2-dimethyl(aminoethyl)methacrylate in nonviral and adenoviral vectors for gene delivery to nasopharyngeal carcinomaJim Moselhy, Swapna Sarkar, Maria C Chia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Imaging and modulating antisense microdistribution in solid human xenograft tumor modelsJoseph D Mocanu, Kenneth W Yip, Julia Skliarenko, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysisAlexander V Louie, George Rodrigues, Malek Hannouf, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|June 6, 2008
The influence of hypoxia on bioluminescence in luciferase-transfected gliosarcoma tumor cells in vitroEduardo H Moriyama, Mark J Niedre, Mark T Jarvi, et al.
Molecular Cancer Therapeutics|September 21, 2006
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agentKenneth W Yip, Emma Ito, Xinliang Mao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancerKenneth W Yip, Wei Shi, Melania Pintilie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screenKenneth W Yip, Xinliang Mao, P Y Billie Au, et al.
Pageof 2